These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15529267)

  • 1. Antibodies directed against O-acetylated sialoglycoconjugates accelerate complement activation in Leishmania donovani promastigotes.
    Bandyopadhyay S; Chatterjee M; Das T; Bandyopadhyay S; Sundar S; Mandal C
    J Infect Dis; 2004 Dec; 190(11):2010-9. PubMed ID: 15529267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans.
    Chava AK; Chatterjee M; Sharma V; Sundar S; Mandal C
    J Infect Dis; 2004 Apr; 189(7):1257-64. PubMed ID: 15031795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients.
    Bandyopadhyay S; Chatterjee M; Pal S; Waller RF; Sundar S; McConville MJ; Mandal C
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):15-24. PubMed ID: 15380274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    Puentes SM; Dwyer DM; Bates PA; Joiner KA
    J Immunol; 1989 Dec; 143(11):3743-9. PubMed ID: 2584716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR; De Messias-Reason IJ
    Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted proteophosphoglycan of Leishmania mexicana amastigotes activates complement by triggering the mannan binding lectin pathway.
    Peters C; Kawakami M; Kaul M; Ilg T; Overath P; Aebischer T
    Eur J Immunol; 1997 Oct; 27(10):2666-72. PubMed ID: 9368624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
    Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
    Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes.
    Chatterjee M; Chava AK; Kohla G; Pal S; Merling A; Hinderlich S; Unger U; Strasser P; Gerwig GJ; Kamerling JP; Vlasak R; Crocker PR; Schauer R; Schwartz-Albiez R; Mandal C
    Glycobiology; 2003 May; 13(5):351-61. PubMed ID: 12626423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic findings in juvenile Mediterranean kala-azar].
    Koletzko B; von Kries R; Wahn V
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):96-9. PubMed ID: 6328286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
    Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ
    Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement activation by a secreted Staphylococcus aureus protein.
    Lee LY; Höök M; Haviland D; Wetsel RA; Yonter EO; Syribeys P; Vernachio J; Brown EL
    J Infect Dis; 2004 Aug; 190(3):571-9. PubMed ID: 15243934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.